ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial...
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, announced that it is planning to expand the development of Gencaro, its lead cardiovascular drug candidate, to atrial...
ARCA biopharma, Inc., a...